CompuGroup Medical SE & Co. KGaA buy RudolfL
Start price
18.02.22
/
60%
€50.90
Target price
08.04.24
€56.00
Performance (%)
-35.36%
End price
07.02.24
€32.90
Summary
This prediction ended on 07.02.24 with a price of €32.90. The BUY prediction by RudolfL for CompuGroup Medical SE & Co. KGaA performed very badly with a performance of -35.36%. Dividends of €0.50 are taken into consideration when calculating the performance. RudolfL has 60% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| CompuGroup Medical SE & Co. KGaA | - | - | - | - |
| iShares Core DAX® | -1,06 % | 5,01 % | 6,60 % | 64,71 % |
| iShares Nasdaq 100 | -2,39 % | 0,86 % | 25,79 % | 88,24 % |
| iShares Nikkei 225® | -4,36 % | 1,21 % | 41,31 % | 79,31 % |
| iShares S&P 500 | -1,78 % | 1,39 % | 21,04 % | 69,60 % |
According to RudolfL what are the pros and cons of CompuGroup Medical SE & Co. KGaA for the foreseeable future?
Pros
EBIT growth >5% per year expected
ROE higher than 15% per year
positive Cash Flow expected
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Cons
Comments by RudolfL for this prediction
In the thread Compugroup Medical SE & Co. KGaA diskutieren
Kursziel gesetzt auf 56,0
In the thread Trading Compugroup Medical SE &co.kgaa
Stopped prediction by RudolfL for CompuGroup Medical SE & Co. KGaA
CompuGroup Medical SE & Co. KGaA
Start price
Target price
Perf. (%)
€80.35
02.09.20
02.09.20
€90.00
04.11.21
04.11.21
-6.85%
08.12.20
08.12.20
EBIT growth >5% per year expected
ROE higher than 15% per year
positive Cash Flow expected
Could be worthwhile Investment >10% per year
